Table of Content


Introduction
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Overview
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Therapeutics Development
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Therapeutics Assessment
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Companies Involved in Therapeutics Development
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Drug Profiles
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Dormant Products
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Discontinued Products
Serine/Threonine Protein Kise PLK1 (Polo Like Kise 1 or Serine/Threonine Protein Kise 13 or PLK1 or EC 2.7.11.21) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, H2 2020
Number of Products under Development by Top 10 Indications, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development by Stage of Development, H2 2020
Number of Products under Development by Therapy Areas, H2 2020
Number of Products under Development by Indications, H2 2020
Number of Products under Development by Indications, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Number of Products under Investigation by Universities/Institutes, H2 2020
Products under Investigation by Universities/Institutes, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Dormant Products, H2 2020
Discontinued Products, H2 2020